Testing effectiveness (Phase 2)Study completedNCT00623324
What this trial is testing
The Effects of Aplindore on the Treatment of Signs and Symptoms of Parkinson's Disease
Who this might be right for
Early Stage Parkinson's Disease
Ligand Pharmaceuticals 40